Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism.
Gutierrez WR, Scherer A, Rytlewski JD, Laverty EA, Sheehan AP, McGivney GR, Brockman QR, Knepper-Adrian V, Roughton GA, Quelle DE, Gordon DJ, Monga V, Dodd RD.
Gutierrez WR, et al. Among authors: gordon dj.
JCI Insight. 2022 Nov 22;7(22):e159419. doi: 10.1172/jci.insight.159419.
JCI Insight. 2022.
PMID: 36227698
Free PMC article.